The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10X Genomics Inc. | COM | 88025U109 | 136,215 | 1,786,431 | SH | SOLE | 1,786,431 | 0 | 0 | ||
| 89Bio Inc | COM | 282559103 | 1,084 | 41,235 | SH | SOLE | 41,235 | 0 | 0 | ||
| Adverum Biotechnologies Inc | COM | 00773U108 | 4,419 | 383,620 | SH | SOLE | 383,620 | 0 | 0 | ||
| Axsome Therapeutics Inc | COM | 05464T104 | 81,239 | 785,981 | SH | SOLE | 785,981 | 0 | 0 | ||
| Bellerophon Therapeutics | COM | 078771102 | 230 | 659,087 | SH | SOLE | 659,087 | 0 | 0 | ||
| Biohaven Pharmaceuticals | COM | G11196105 | 25,200 | 462,903 | SH | SOLE | 462,903 | 0 | 0 | ||
| Constellation Pharmaceuticals | COM | 210373106 | 70,695 | 1,500,631 | SH | SOLE | 1,500,631 | 0 | 0 | ||
| Forty Seven Inc | COM | 34983P104 | 3,060 | 77,714 | SH | SOLE | 77,714 | 0 | 0 | ||
| Iveric Bio Inc | COM | 46583P102 | 8,617 | 1,004,299 | SH | SOLE | 1,004,299 | 0 | 0 | ||
| Kalvista Pharmaceuticals | COM | 483497103 | 6,523 | 366,268 | SH | SOLE | 366,268 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | 3,211 | 1,486,676 | SH | SOLE | 1,486,676 | 0 | 0 | ||
| Mersana Therapeutics Inc | COM | 59045L106 | 5,286 | 922,514 | SH | SOLE | 922,514 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc | COM | 59935V107 | 2,378 | 148,560 | SH | SOLE | 148,560 | 0 | 0 | ||
| Myovant Sciences Ltd | COM | G637AM102 | 1,191 | 76,768 | SH | SOLE | 76,768 | 0 | 0 | ||
| Nextcure Inc | COM | 65343E108 | 2,042 | 36,249 | SH | SOLE | 36,249 | 0 | 0 | ||
| Obseva SA | COM | H5861P103 | 6,011 | 1,573,639 | SH | SOLE | 1,573,639 | 0 | 0 | ||
| Protagonist Therapeutics Inc | COM | 74366E102 | 227 | 32,211 | SH | SOLE | 32,211 | 0 | 0 | ||
| Relmada Therapeutics Inc | COM | 75955J402 | 4,480 | 114,876 | SH | SOLE | 114,876 | 0 | 0 | ||
| Shockwave Medical Inc | COM | 82489T104 | 12,686 | 288,838 | SH | SOLE | 288,838 | 0 | 0 | ||
| Spero Therapeutics Inc | COM | 84833T103 | 4,558 | 474,015 | SH | SOLE | 474,015 | 0 | 0 | ||